Company news
Rani Therapeutics Holdings, Inc. news in 2023
Rani Therapeutics Holdings, Inc.'s news releases, calls and decks from 2023, newest first.
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
December 13, 2023
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
November 7, 2023
Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Thir...
October 31, 2023
The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study
October 24, 2023
Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study
October 18, 2023
Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
October 11, 2023
Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)
September 17, 2023
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
September 6, 2023
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
August 10, 2023
Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference
June 7, 2023
Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105
June 4, 2023
Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference
May 30, 2023
Rani Therapeutics Appoints Kate McKinley as Chief Business Officer
May 23, 2023
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
March 21, 2023
Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update
January 4, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (September 2023)
Investor deck · 38 slides · Sep 7, 2023